202 related articles for article (PubMed ID: 21191784)
1. Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes.
Saleh MA; Boesen EI; Pollock JS; Savin VJ; Pollock DM
Diabetologia; 2011 Apr; 54(4):979-88. PubMed ID: 21191784
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat.
Saleh MA; Boesen EI; Pollock JS; Savin VJ; Pollock DM
Hypertension; 2010 Nov; 56(5):942-9. PubMed ID: 20823379
[TBL] [Abstract][Full Text] [Related]
3. Distinct actions of endothelin A-selective versus combined endothelin A/B receptor antagonists in early diabetic kidney disease.
Saleh MA; Pollock JS; Pollock DM
J Pharmacol Exp Ther; 2011 Jul; 338(1):263-70. PubMed ID: 21471190
[TBL] [Abstract][Full Text] [Related]
4. Combined endothelin a blockade and chlorthalidone treatment in a rat model of metabolic syndrome.
Jin C; Jeon Y; Kleven DT; Pollock JS; White JJ; Pollock DM
J Pharmacol Exp Ther; 2014 Nov; 351(2):467-73. PubMed ID: 25189702
[TBL] [Abstract][Full Text] [Related]
5. ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain.
Jarvis MF; Wessale JL; Zhu CZ; Lynch JJ; Dayton BD; Calzadilla SV; Padley RJ; Opgenorth TJ; Kowaluk EA
Eur J Pharmacol; 2000 Jan; 388(1):29-35. PubMed ID: 10657544
[TBL] [Abstract][Full Text] [Related]
6. Renal and systemic effects of chronic blockade of ET(A) or ET(B) receptors in normal rats and animals with experimental heart failure.
Francis B; Winaver J; Karram T; Hoffman A; Abassi Z
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S54-8. PubMed ID: 15838359
[TBL] [Abstract][Full Text] [Related]
7. Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism.
Sasser JM; Sullivan JC; Hobbs JL; Yamamoto T; Pollock DM; Carmines PK; Pollock JS
J Am Soc Nephrol; 2007 Jan; 18(1):143-54. PubMed ID: 17167119
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation.
Banes-Berceli AK; Ketsawatsomkron P; Ogbi S; Patel B; Pollock DM; Marrero MB
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1291-9. PubMed ID: 17526654
[TBL] [Abstract][Full Text] [Related]
9. Endothelin receptor a blockade is an ineffective treatment for adriamycin nephropathy.
Tan RJ; Zhou L; Zhou D; Lin L; Liu Y
PLoS One; 2013; 8(11):e79963. PubMed ID: 24265790
[TBL] [Abstract][Full Text] [Related]
10. Free radical scavenging decreases endothelin-1 excretion and glomerular albumin permeability during type 1 diabetes.
Saleh MA; De Miguel C; Stevens DI; Carmines PK; Pollock DM; Pollock JS
Physiol Rep; 2016 Dec; 4(24):. PubMed ID: 28039404
[TBL] [Abstract][Full Text] [Related]
11. Effect of endothelin receptor antagonists on ventricular susceptibility in postinfarcted rats.
Lee TM; Chen CC; Lin MS; Chang NC
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1871-9. PubMed ID: 18281380
[TBL] [Abstract][Full Text] [Related]
12. RhoA/ROCK inhibition attenuates endothelin-1-induced glomerulopathy in the rats.
Saleh MA; Shaaban AA; Talaat IM; Elmougy A; Adra SF; Ahmad F; Qaisar R; Elmoselhi AB; Abu-Gharbieh E; El-Huneidi W; Eladl MA; Shehatou G; Kafl HE
Life Sci; 2023 Jun; 323():121687. PubMed ID: 37030613
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier.
McCarthy ET; Sharma R; Sharma M
Kidney Int; 2005 Jan; 67(1):152-6. PubMed ID: 15610238
[TBL] [Abstract][Full Text] [Related]
14. Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat model.
Battistini B; Verreault M; Ayach B; Blouin A; Cernacek P; Jeng AY; Wessale J; Opgenorth T; Tsang J
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S386-9. PubMed ID: 15838327
[TBL] [Abstract][Full Text] [Related]
15. ET-1 increases reactive oxygen species following hypoxia and high-salt diet in the mouse glomerulus.
Heimlich JB; Speed JS; Bloom CJ; O'Connor PM; Pollock JS; Pollock DM
Acta Physiol (Oxf); 2015 Mar; 213(3):722-30. PubMed ID: 25219340
[TBL] [Abstract][Full Text] [Related]
16. Chronic endothelin-1 infusion elevates glomerular sieving coefficient and proximal tubular albumin reuptake in the rat.
Saleh MA; Sandoval RM; Rhodes GJ; Campos-Bilderback SB; Molitoris BA; Pollock DM
Life Sci; 2012 Oct; 91(13-14):634-7. PubMed ID: 22727794
[TBL] [Abstract][Full Text] [Related]
17. Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis.
Ebihara I; Nakamura T; Tomino Y; Koide H
Nephrol Dial Transplant; 1997 May; 12(5):1001-6. PubMed ID: 9175058
[TBL] [Abstract][Full Text] [Related]
18. Sustained, delayed, and small increments in glomerular permeability to macromolecules during systemic ET-1 infusion mediated via the ET
Dolinina J; Rippe A; Öberg CM
Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1173-F1179. PubMed ID: 30864842
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine A-induced increase in glomerular cyclic GMP in rats and the involvement of the endothelinB receptor.
Tack I; Marin-Castano E; Bascands JL; Pecher C; Ader JL; Girolami JP
Br J Pharmacol; 1997 Jun; 121(3):433-40. PubMed ID: 9179384
[TBL] [Abstract][Full Text] [Related]
20. Effects of endothelin receptor antagonists on the progression of diabetic nephropathy.
Hocher B; Schwarz A; Reinbacher D; Jacobi J; Lun A; Priem F; Bauer C; Neumayer HH; Raschack M
Nephron; 2001 Feb; 87(2):161-9. PubMed ID: 11244312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
